A novel PCR-based method for direct Fcγ receptor IIIa (CD16) allotyping

Journal of Immunological Methods

Volumn 242, Issue 1-2, 2000, Pages 127-132

  Leppers Van De Straat, F G J ^a   Van Der Pol, W L ^a   Jansen, M D ^a   Sugita, N ^b   Yoshie, H ^b   Kobayashi, T ^b   Van De Winkel, J G J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Ethnicity; Fc RIIIa; PCR; Polymorphism

Indexed keywords

CD16 ANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G;

ALLOTYPE; ARTICLE; CLINICAL ARTICLE; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMMUNOMODULATION; JAPAN; NETHERLANDS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALLELES; CAUCASOID RACE; GENE FREQUENCY; GENOTYPE; HUMAN; IMMUNOGLOBULIN ALLOTYPES; JAPAN; MONGOLOID RACE; NETHERLANDS; POLYMERASE CHAIN REACTION; RECEPTORS, IGG; REPRODUCIBILITY OF RESULTS; SUPPORT, NON-U.S. GOV'T;

EID: 0034726416     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(00)00240-4     Document Type: Article

References (21)

1. Abo T., Tilden A.B., Balch C.M., Kumagai K., Troup G.M., Cooper M.D. Ethnic differences in the lymphocyte proliferative response induced by a murine IgG1 antibody, Leu-4, to the T3 molecule. J. Exp. Med. 160:1984;303.
2. Bolland S., Ravetch J.V. Inhibitory pathways triggered by ITIM-containing receptors. Adv. Immunol. 72:1999;149.
3. Botto M., Theodoridis E., Thompson E.M., Beynon H.L.C., Briggs D., Isenberg D.A., Walport M.J., Davies K.A. FcγRIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin. Exp. Immunol. 104:1996;264.
4. Dijstelbloem H., Scheepers R.H.M., Oost W.W., Stegeman C.A., Van der Pol W.-L., Sluiter W.J., Kallenberg C.G.M., Van de Winkel J.G.J., Cohen Tervaert J.W.C. Fcγ receptor polymorphism in Wegener's granulomatosis. Arthritis Rheum. 42:1999;1823.
5. Clynes R., Maizes J.S., Guinamard R., Ono M., Takai T., Ravetch J.V. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J. Exp. Med. 189:1999;179.
6. Haung M.M., Arnheim N., Goodman M.F. Extension of base mispairs by Taq DNA polymerase; implications for single nucleotide discrimination in PCR. Nucleic Acid Res. 20:1992;4567.
7. Kobayashi T., Westerdaal N.A.C., Miyazaki A., van der Pol W.-L., Suzuki T., Yoshie H., van de Winkel J.G.J., Hara K. Relevance of immunoglobulin G Fc receptor polymorphism to recurrence of adult periodontitis in Japanese patients. Infect. Immun. 65:1997;3556.
8. Koene H.R., Kleijer M., Algra J., Roos D., von dem Borne A.E.G.K., de Haas M. FcγRIIIa-158V/F polymorphism influences the binding of IgG by NK cell FcγRIIIa, independently of the FcγRIIIa-48L/R/H phenotype. Blood. 90:1997;1109.
9. Koene H.R., Kleijer M., Swaak A.J.G., Sullivan K.E., Bijl M., Petri M.A., Kallenberg C.G.M., Roos D., VondemBorne A.E.G.K., DeHaas M. The FcγRIIIA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis Rheum. 41:1998;1813.
10. Lehrnbecher T., Foster C.B., Zhu S., Leitman S.F., Goldin L.R., Huppi K., Chanock S.J. Variant genotypes of the low-affinity Fcγ receptors in two control populations and a review of low-affinity Fcγ receptor polymorphisms in control and disease populations. Blood. 94:1999;4220.
11. Oh M., Petri M.A., Kim N.A., Sullivan K.E. Frequency of the Fcγ RIIIa-158F allele in African American patients with systemic lupus erythematosus. J. Rheumatol. 26:1999;1486.
12. Osborne J.M., Chacko G.W., Brandt J.T., Anderson C.L. Ethnic variation in frequency of an allelic polymorphism of human FcγRIIa determined with allele specific oligonucleotide probes. J. Immunol. Methods. 173:1994;207.
13. Rascu A., Repp R., Westerdaal N.A.C., Kalden J.R., van de Winkel J.G.J. Clinical relevance of FcγR polymorphisms. Ann. NY Acad. Sci. 815:1997;282.
14. Ravetch J.V., Perussia B. Alternative membrane forms of FcγRIII (CD16) on human natural killer cells and neutrophils. J. Exp. Med. 170:1989;481.
15. Salmon J.E., Ng S., Yoo D.H., Kim T.H., Kim S.Y., Song G.G. Altered distribution of Fcγ receptor IIIA alleles in a cohort of Korean patients with lupus nephritis. Arthritis Rheum. 42:1999;818.
16. Smyth L.J.C., Snowden N., Carthy D., Papasteriades C., Hajeer A., Ollier W.E.R. FcγRIIa polymorphism in systemic lupus erythematosus. Ann. Rheum. Dis. 56:1997;744.
17. Song Y.W., Han C.-W., Kang S.-W., Baek H.-J., Lee E.-B., Shin C.-H., Hahn B.H., Tsao B.P. Abnormal distribution of Fcγ receptor type IIa polymorphisms in Korean patients with systemic lupus erythematosus. Arthritis Rheum. 41:1998;421.
18. Sugita N., Yamamoto K., Kobayashi T., Van der Pol W.-L., Horigome T., Yoshie H., Van de Winkel J.G.J., Hara K. Relevance of FcγRIIIa-158V-F polymorphism to recurrence of adult periodontitis in Japanese patients. Clin. Exp. Immunol. 117:1999;35.
19. Van der Pol W.-L., Van de Winkel J.G.J. IgG receptor polymorphisms: risk factors for disease. Immunogenetics. 48:1998;222.
20. Van de Winkel J.G.J., Capel P.J.A. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol. Today. 14:1993;215.
21. Wu J., Edberg J.C., Redecha P.B., Bansal V., Guyre P.M., Coleman K., Salmon J.E., Kimberly R.P. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J. Clin. Invest. 100:1997;1059.